How much is the latest price of a bottle of domestically produced pomalidomide?

Domestic pomalidomide (Pomalidomide), as a key targeted drug for the treatment of multiple myeloma and other blood tumors, has been officially launched in China and included in the national medical insurance directory. This means that eligible patients can alleviate part of their financial burden through medical insurance reimbursement and obtain more convenient drug supply. Nonetheless, since the drug itself is an innovative drug, its price is still relatively high. Specifically, prices will vary in different regions and hospitals, and patients should refer to the price quoted by the local hospital pharmacy when actually purchasing drugs.

Under the medical insurance reimbursement policy, the actual cost paid by patients is generally significantly lower than the original retail price of the drug. The coverage ratio of medical insurance varies depending on regional policies. In some places, the reimbursement ratio of medical insurance can reach about 70%-90%, which greatly alleviates the financial pressure on patients. However, the out-of-pocket portion after medical insurance reimbursement still needs to be borne by the patient, especially in some economically underdeveloped areas, where drug costs are still a major burden in patient treatment. It is recommended that patients consult local medical insurance and hospital relevant departments in detail before purchasing drugs to understand the specific reimbursement policies and out-of-pocket amounts.

It is worth noting that there are generic pomalidomide drugs produced in Laos and other countries on the foreign market, and the price is relatively low, about more than 300 yuan per box. Although these generic drugs are cheap, their quality, efficacy and safety need to be strictly controlled. When considering using imported generic drugs, patients should ensure that they come from regular sources and use them under the guidance of a doctor. In contrast, domestic original research or officially authorized generic drugs are more secure in terms of quality supervision and drug supply chain, and are suitable for most patients' long-term standardized medication.

Generally speaking, although the price of domestic pomalidomide is relatively high, the financial pressure on patients has been alleviated to a certain extent through the medical insurance reimbursement mechanism. When choosing medication, patients should give priority to purchasing through formal channels and cooperate with doctors to formulate scientific and reasonable treatment plans. At the same time, it is recommended that patients pay attention to policy trends, understand the latest medical insurance information, strive to enjoy more medical insurance discounts, effectively ensure the continuity and safety of treatment, and achieve effective management of diseases.

Reference materials:https://www.drugs.com/